Biopreservation Market Report 2025

The biopreservation market market size has grown rapidly in recent years. It will grow from $6.02 billion in 2024 to $6.7 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to biobanking expansion, rise in stem cell research, growing organ transplantation procedures, biopharmaceutical production, cell therapy advancement.

The biopreservation market market size is expected to see rapid growth in the next few years. It will grow to $11.09 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine, R&D in personalized medicine, cryopreservation applications, global biopharmaceutical supply chain, emerging biobanking initiatives. Major trends in the forecast period include growing application in stem cell banking, focus on advanced preservation solutions, expansion in drug discovery and development, introduction of portable biopreservation devices, growing importance in organ transplantation.

The growing demand for personalized medicine is playing a significant role in the expansion of the biopreservation market. Personalized medicine focuses on treating patients with therapies tailored to their specific diseases. The development of these personalized medicines relies on biobanks, which store human tissues and cells through biopreservation techniques. For example, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported in February 2024 that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, an increase from six approvals in 2022. Therefore, the rising demand for personalized medicine is expected to drive growth in the biopreservation market in the future.

The rising prevalence of chronic diseases is anticipated to significantly drive the growth of the biopreservation market in the future. Chronic diseases are long-term health conditions that can last throughout a person's life. Biopreservation is essential for managing chronic diseases as it facilitates the storage and preservation of biological samples, such as cells and tissues, for research, diagnostic, and therapeutic applications. This process aids in understanding, treating, and potentially curing various chronic conditions. For instance, the World Health Organization, a Switzerland-based agency of the United Nations, projected in February 2024 that over 35 million new cancer cases will emerge by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Thus, the growing prevalence of chronic diseases is fueling the expansion of the biopreservation market.

Technological innovation is a significant trend in the biopreservation market. Key players are increasingly adopting new technologies, such as cryopreservation solutions, to preserve complex tissues and organs over time. Cryopreservation involves storing biological materials at extremely low temperatures (-196 °C), either rapidly, as seen in seed storage, or gradually with simultaneous dehydration, as in tissue culture. For example, in April 2024, Pluristyx, Inc., a biotechnology company based in the U.S., introduced PluriFreeze Cryopreservation Media. This proprietary solution is designed to improve the viability and functionality of human-derived pluripotent stem cells (iPSCs) and other sensitive cell types during the freezing and thawing processes. Initially offered in a research-use-only (RUO) formulation, a good manufacturing practice (GMP) version is anticipated soon. PluriFreeze is entirely composed of synthetic and animal-origin-free (AOF) materials, ensuring a safer and more ethical approach to cell preservation. Its low viscosity promotes automation and large-scale cell production, while the complementary DMSO-free wash solution, PluriPrep, extends processing times, optimizing cell handling and recovery for both research and clinical purposes.

Major companies in the biopreservation market are prioritizing the development of innovative products, such as controlled-rate freezers, to improve the preservation of biological samples. A Controlled-Rate Freezer (CRF) is a specialized device designed to precisely manage the cooling process of biological samples, pharmaceuticals, and other temperature-sensitive materials. For instance, in June 2023, BioLife Solutions Inc., a U.S.-based life sciences company, introduced the IntelliRate i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer. This advanced device is specifically designed for the controlled freezing of biological materials, making it particularly suitable for cell and gene therapies. It features a substantial internal capacity of 67 liters (2.35 cu. ft.), offering 40% more storage space than competing tabletop controlled-rate freezers. This capacity enables it to hold 2,166 2mL vials or a flexible combination of bags and cassettes, optimizing storage efficiency. Additionally, the freezer is equipped with the largest touchscreen controller in its category, which allows for user-friendly operation and access to a wide range of preset and customizable freezing protocols. It also complies with 21 CFR Part 11 standards for freezing profiles, ensuring adherence to essential regulatory requirements for clinical applications.

In June 2024, DefiniGEN Ltd., a biotechnology company based in the UK, announced a partnership with Atelerix Ltd. for an undisclosed amount. This collaboration aims to improve the efficiency and sustainability of drug testing by facilitating the shipping of functional in vitro liver models without requiring cold chain logistics. Atelerix Ltd. is also a UK-based biotechnology company that specializes in developing and commercializing innovative cell-based therapies and regenerative medicine solutions.

Major companies operating in the biopreservation market market include Thermo Fisher Scientific Inc., BioLife Solutions Inc., VWR International LLC, BioCision LLC, Lifeline Scientific Inc., Biomatrica Inc., Custom Biogenic System Inc., QIAGEN NV, ThermoGenesis Holdings Inc., MVE Biological Solutions LLC, Taylor-Wharton America Inc., X-Therma Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., The Merck Group, Azenta US Inc., Avantor Inc., Bio-Techne Corporation, Worthington Industries Inc., Chart Industries Inc., Cryoport Inc., LabVantage Solutions Inc., Brooks Automation Inc., BioVault Technical Ltd., Biomatik Corporation, Biostorage Technologies Inc., Arctiko A/S, Eppendorf AG, Panasonic Healthcare Co. Ltd., BioSpherix Ltd.

North America was the largest region in the biopreservation market share in 2024. The regions covered in the biopreservation market market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biopreservation market market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biopreservation involves the utilization of microorganisms and their metabolic byproducts to enhance food safety and extend the shelf life of products. It's also employed to safeguard biospecimens, maintaining their integrity and protecting them from external harm beyond their natural environment. Biospecimens encompass materials such as urine, blood, tissues, cells, DNA, among others, stored in biorepositories for future research or diagnostic purposes.

The primary categories of biopreservation include biopreservation equipment and biopreservation media. Biopreservation equipment consists of instruments such as bio-based therapeutics, clinical biomarkers, cells, viruses, diagnostic biochips, and other tools utilized to preserve biospecimens. This preservation technique is applied across various biospecimens, including human tissue samples, organs, stem cells, among others. It finds applications in therapeutic use, research, clinical trials, and is commonly employed by biobanks, gene banks, hospitals, and similar entities.

The biopreservation market research report is one of a series of new reports that provides biopreservation market statistics, including biopreservation industry global market size, regional shares, competitors with a biopreservation market share, detailed biopreservation market segments, market trends and opportunities, and any further data you may need to thrive in the biopreservation industry. This biopreservation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopreservation market includes revenues earned by entities by providing freezing services, cryogenic storage system services, thawing equipment, and sample refrigeration services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.